β-Catenin Signaling in Fibroproliferative Disease

Journal of Surgical Research

Volumn 138, Issue 1, 2007, Pages 141-150

  Bowley, Erin ^a,b   O'Gorman, David B ^a,b   Gan, Bing Siang ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Dupuytren's contracture; fibroproliferative disorders; hypertrophic scarring; Wnt beta catenin signaling; wound healing

Indexed keywords

BETA CATENIN; WNT PROTEIN;

ARTICLE; CELL PROLIFERATION; DUPUYTREN CONTRACTURE; FIBROMATOSIS; GENETIC TRANSCRIPTION; HUMAN; HYPERTROPHIC SCAR; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; TRANSACTIVATION; WOUND HEALING;

ANIMALS; BETA CATENIN; CICATRIX; DUPUYTREN CONTRACTURE; FIBROMA; FIBROSIS; HUMANS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; WOUND HEALING;

EID: 33846869496     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.07.026     Document Type: Article

References (113)

1. Korswagen H.C. Canonical and non-canonical Wnt signaling pathways in Caenorhabditis elegans: Variations on a common signaling theme. Bioessays 24 (2002) 801
2. Smalley M.J., and Dale T.C. Wnt signalling in mammalian development and cancer. Cancer Metastasis Rev 18 (1999) 215
3. Nelson W.J., and Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303 (2004) 1483
4. Wehrli M., Dougan S.T., Caldwell K., et al. Arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407 (2000) 527
5. Tamai K., Semenov M., Kato Y., et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 407 (2000) 530
6. Pinson K.I., Brennan J., Monkley S., Avery B.J., and Skarnes W.C. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407 (2000) 535
7. Amit S., Hatzubai A., Birman Y., et al. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: A molecular switch for the Wnt pathway. Genes Dev 16 (2002) 1066
8. Dixelius J., Cross M., Matsumoto T., Sasaki T., Timpl R., and Claesson-Welsh L. Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res 62 (2002) 1944
9. Yanagawa S., Matsuda Y., Lee J.S., et al. Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila. Embo J 21 (2002) 1733
10. Aberle H., Bauer A., Stappert J., Kispert A., and Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. Embo J 16 (1997) 3797
11. Giles R.H., van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653 (2003) 1
12. Miller J.R., Hocking A.M., Brown J.D., and Moon R.T. Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 18 (1999) 7860
13. Orford K., Crockett C., Jensen J.P., Weissman A.M., and Byers S.W. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 272 (1997) 24735
14. Hart M., Concordet J.P., Lassot I., et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 9 (1999) 207
15. Latres E., Chiaur D.S., and Pagano M. The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin. Oncogene 18 (1999) 849
16. Winston J.T., Strack P., Beer-Romero P., Chu C.Y., Elledge S.J., and Harper J.W. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 13 (1999) 270
17. Krieghoff E., Behrens J., and Mayr B. Nucleo-cytoplasmic distribution of {beta}-catenin is regulated by retention. J Cell Sci 119 (2006) 1453
18. Behrens J., von Kries J.P., Kuhl M., et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382 (1996) 638
19. Morin P.J., Sparks A.B., Korinek V., et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 (1997) 1787
20. Molenaar M., van de Wetering M., Oosterwegel M., et al. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86 (1996) 391
21. Cadigan K.M., and Nusse R. Wnt signaling: A common theme in animal development. Genes Dev 11 (1997) 3286
22. Mulholland D.J., Dedhar S., Coetzee G.A., and Nelson C.C. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know. Endocr Rev 26 (2005) 898
23. Nusse R. Wnt signaling in disease and in development. Cell Res 15 (2005) 28
24. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20 (2004) 781
25. Moon R.T., Kohn A.D., De Ferrari G.V., and Kaykas A. WNT and beta-catenin signalling: Diseases and therapies. Nat Rev Genet 5 (2004) 691
26. Yardy G.W., and Brewster S.F. Wnt signalling and prostate cancer. Prostate Cancer Prostatic Dis 8 (2005) 119
27. Kolligs F.T., Bommer G., and Goke B. Wnt/beta-catenin/tcf signaling: A critical pathway in gastrointestinal tumorigenesis. Digestion 66 (2002) 131
28. Maruyama K., Ochiai A., Akimoto S., et al. Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology 59 (2000) 302
29. Groden J., Thliveris A., Samowitz W., et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66 (1991) 589
30. de La Costeqq A., Romagnolo B., Billuart P., et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95 (1998) 8847
31. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159
32. Hsu H.C., Jeng Y.M., Mao T.L., Chu J.S., Lai P.L., and Peng S.Y. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 157 (2000) 763
33. Grabsch H., Takeno S., Noguchi T., Hommel G., Gabbert H.E., and Mueller W. Different patterns of beta-catenin expression in gastric carcinomas: Relationship with clinicopathological parameters and prognostic outcome. Histopathology 39 (2001) 141
34. Desbois-Mouthon C., Cadoret A., Blivet-Van Eggelpoel M.J., et al. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene 20 (2001) 252
35. Chen E.Y., Mazure N.M., Cooper J.A., and Giaccia A.J. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res 61 (2001) 2429
36. Cheng J.Q., Lindsley C.W., Cheng G.Z., Yang H., and Nicosia S.V. The Akt/PKB pathway: Molecular target for cancer drug discovery. Oncogene 24 (2005) 7482
37. Chen Y.L., Law P.Y., and Loh H.H. Inhibition of PI3K/Akt signaling: An emerging paradigm for targeted cancer therapy. Curr Med Chem Anticancer Agents 5 (2005) 575
38. Jun J.B., Kuechle M., Min J., et al. Scleroderma fibroblasts demonstrate enhanced activation of Akt (protein kinase B) in situ. J Invest Dermatol 124 (2005) 298
39. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785
40. Mulholland D.J., Dedhar S., Wu H., and Nelson C.C. PTEN and GSK3beta: Key regulators of progression to androgen-independent prostate cancer. Oncogene 25 (2006) 329
41. Brakebusch C., and Fassler R. The integrin-actin connection, an eternal love affair. Embo J 22 (2003) 2324
42. Hynes R.O. Integrins: Bidirectional, allosteric signaling machines. Cell 110 (2002) 673
43. Nho R.S., Xia H., Kahm J., Kleidon J., Diebold D., and Henke C.A. Role of integrin-linked kinase in regulating phosphorylation of Akt and fibroblast survival in type I collagen matrices through a beta1 integrin viability signaling pathway. J Biol Chem 280 (2005) 26630
44. D'Amico M., Hulit J., Amanatullah D.F., et al. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275 (2000) 32649
45. Tan C., Costello P., Sanghera J., et al. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Oncogene 20 (2001) 133
46. Wheelock M.J., and Johnson K.R. Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 19 (2003) 207
47. Kintner C. Regulation of embryonic cell adhesion by the cadherin cytoplasmic domain. Cell 69 (1992) 225
48. Nagafuchi A., and Takeichi M. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. Embo J 7 (1988) 3679
49. Cheon S., Poon R., Yu C., et al. Prolonged beta-catenin stabilization and tcf-dependent transcriptional activation in hyperplastic cutaneous wounds. Lab Invest 85 (2005) 416
50. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., and Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110 (2002) 341
51. Kalluri R., and Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112 (2003) 1776
52. Meniel V., and Clarke A.R. Wnt-cadherin connections in normal and neoplastic mammary epithelium. J Mammary Gland Biol Neoplasia 8 (2003) 435
53. Krishnadath K.K., Tilanus H.W., van Blankenstein M., et al. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 182 (1997) 331
54. Beltran P.J., and Bixby J.L. Receptor protein tyrosine phosphatases as mediators of cellular adhesion. Front Biosci 8 (2003) d87
55. Potempa S., and Ridley A.J. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol Biol Cell 9 (1998) 2185
56. Kimura T., Sakisaka T., Baba T., Yamada T., and Takai Y. Involvement of the Ras-Ras-activated Rab5 guanine nucleotide exchange factor RIN2-Rab5 pathway in the HGF-induced endocytosis of E-cadherin. J Biol Chem 281 (2006) 10598
57. Muller T., Bain G., Wang X., and Papkoff J. Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp Cell Res 280 (2002) 119
58. Fukuyama R., and Shimizu N. Detection of epidermal growth factor receptors and E-cadherins in the basolateral membrane of A431 cells by laser scanning fluorescence microscopy. Jpn J Cancer Res 82 (1991) 8
59. Hoschuetzky H., Aberle H., and Kemler R. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 127 (1994) 1375
60. Shibamoto S., Hayakawa M., Takeuchi K., et al. Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun 1 (1994) 295
61. Kitada T., Miyoshi E., Noda K., et al. The addition of bisecting N-acetylglucosamine residues to E-cadherin down-regulates the tyrosine phosphorylation of beta-catenin. J Biol Chem 276 (2001) 475
62. Bek S., and Kemler R. Protein kinase CKII regulates the interaction of beta-catenin with alpha-catenin and its protein stability. J Cell Sci 115 (2002) 4743
63. Lickert H., Bauer A., Kemler R., and Stappert J. Casein kinase II phosphorylation of E-cadherin increases E-cadherin/beta-catenin interaction and strengthens cell-cell adhesion. J Biol Chem 275 (2000) 5090
64. Behrens J., Vakaet L., Friis R., et al. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 120 (1993) 757
65. Taddei M.L., Chiarugi P., Cirri P., et al. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. Cancer Res 62 (2002) 6489
66. Piedra J., Miravet S., Castano J., et al. p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction. Mol Cell Biol 23 (2003) 2287
67. Lilien J., and Balsamo J. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol 17 (2005) 459
68. Hulsken J., Birchmeier W., and Behrens J. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 127 (1994) 2061
69. Gavard J., and Mege R.M. Once upon a time there was beta-catenin in cadherin-mediated signalling. Biol Cell 97 (2005) 921
70. Gottardi C.J., and Gumbiner B.M. Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes. J Cell Biol 167 (2004) 339
71. Duchesne C., Charland S., Asselin C., Nahmias C., and Rivard N. Negative regulation of beta-catenin signaling by tyrosine phosphatase SHP-1 in intestinal epithelial cells. J Biol Chem 278 (2003) 14274
72. Playford M.P., Bicknell D., Bodmer W.F., and Macaulay V.M. Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin. Proc Natl Acad Sci USA 97 (2000) 12103
73. Herynk M.H., Tsan R., Radinsky R., and Gallick G.E. Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin. Clin Exp Metastasis 20 (2003) 291
74. Morali O.G., Delmas V., Moore R., Jeanney C., Thiery J.P., and Larue L. IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 20 (2001) 4942
75. Singer A.J., and Clark R.A. Cutaneous wound healing. N Engl J Med 341 (1999) 738
76. Cheon S.S., Cheah A.Y., Turley S., et al. Beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci USA 99 (2002) 6973
77. Cheon S.S., Nadesan P., Poon R., and Alman B.A. Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing. Exp Cell Res 293 (2004) 267
78. Werner S., and Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 83 (2003) 835
79. Annes J.P., Munger J.S., and Rifkin D.B. Making sense of latent TGFbeta activation. J Cell Sci 116 (2003) 217
80. Flanders K.C. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 85 (2004) 47
81. Falanga V., Schrayer D., Cha J., Butmarc J., Carson P., Roberts A.B., and Kim S.J. Full-thickness wounding of the mouse tail as a model for delayed wound healing: Accelerated wound closure in Smad3 knock-out mice. Wound Repair Regen 12 (2004) 320
82. Ashcroft G.S., Yang X., Glick A.B., et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1 (1999) 260
83. Cheon S.S., Wei Q., Gurung A., et al. Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing. FASEB J 20 (2006) 692
84. Nayeri F., Olsson H., Peterson C., and Sundqvist T. Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers. J Dermatol Sci 37 (2005) 75
85. Nayeri F., Stromberg T., Larsson M., Brudin L., Soderstrom C., and Forsberg P. Hepatocyte growth factor may accelerate healing in chronic leg ulcers: A pilot study. J Dermatolog Treat 13 (2002) 81
86. Stojadinovic O., Brem H., Vouthounis C., et al. Molecular pathogenesis of chronic wounds: The role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 167 (2005) 59
87. Posthaus H., Williamson L., Baumann D., et al. Beta-Catenin is not required for proliferation and differentiation of epidermal mouse keratinocytes. J Cell Sci 115 (2002) 4587
88. Bhattacharya B., Dilworth H.P., Iacobuzio-Donahue C., et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 29 (2005) 653
89. Alman B.A., Pajerski M.E., Diaz-Cano S., Corboy K., and Wolfe H.J. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol 6 (1997) 98
90. Kinzler K.W., Nilbert M.C., Su L.K., et al. Identification of FAP locus genes from chromosome 5q21. Science 253 (1991) 661
91. Tejpar S., Nollet F., Li C., et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18 (1999) 6615
92. Alman B.A., Li C., Pajerski M.E., Diaz-Cano S., and Wolfe H.J. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 151 (1997) 329
93. Tejpar S., Li C., Yu C., et al. Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour). Br J Cancer 85 (2001) 98
94. Rakheja D., Molberg K.H., Roberts C.A., and Jaiswal V.R. Immunohistochemical expression of beta-catenin in solitary fibrous tumors. Arch Pathol Lab Med 129 (2005) 776
95. Bach L.A. Insulin-like growth factor binding protein-6: the "forgotten" binding protein?. Horm Metab Res 31 (1999) 226
96. Denys H., Jadidizadeh A., Amini Nik S., et al. Identification of IGFBP-6 as a significantly downregulated gene by beta-catenin in desmoid tumors. Oncogene 23 (2004) 654
97. Skubitz K.M., and Skubitz A.P. Gene expression in aggressive fibromatosis. J Lab Clin Med 143 (2004) 89
98. Grotendorst G.R., Rahmanie H., and Duncan M.R. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 18 (2004) 469
99. Bisson M.A., Mudera V., McGrouther D.A., and Grobbelaar A.O. The contractile properties and responses to tensional loading of Dupuytren's disease-derived fibroblasts are altered: A cause of the contracture?. Plast Reconstr Surg 113 (2004) 611 discussion 622
100. Kloen P. New insights in the development of Dupuytren's contracture: A review. Br J Plast Surg 52 (1999) 629
101. Rayan G.M. Palmar fascial complex anatomy and pathology in Dupuytren's disease. Hand Clin 15 (1999) 73
102. Bisson M.A., McGrouther D.A., Mudera V., and Grobbelaar A.O. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: Expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1. J Hand Surg [Br] 28 (2003) 351
103. Brickley-Parsons D., Glimcher M.J., Smith R.J., Albin R., and Adams J.P. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg Am 63 (1981) 787
104. Alioto R.J., Rosier R.N., Burton R.I., and Puzas J.E. Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia. J Hand Surg [Am] 19 (1994) 442
105. Varallo V.M., Gan B.S., Seney S., et al. Beta-catenin expression in Dupuytren's disease: Potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitro. Oncogene 22 (2003) 3680
106. Howard J.C., Varallo V.M., Ross D.C., et al. Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro. BMC Musculoskelet Disord 4 (2003) 16
107. Montgomery E., Lee J.H., Abraham S.C., and Wu T.T. Superficial fibromatoses are genetically distinct from deep fibromatoses. Mod Pathol 14 (2001) 695
108. Bunker T.D., and Anthony P.P. The pathology of frozen shoulder. A Dupuytren-like disease. J Bone Joint Surg Br 77 (1995) 677
109. Bunker T.D., Reilly J., Baird K.S., and Hamblen D.L. Expression of growth factors, cytokines and matrix metalloproteinases in frozen shoulder. J Bone Joint Surg [Br] 82 (2000) 768
110. Smith S.P., Devaraj V.S., and Bunker T.D. The association between frozen shoulder and Dupuytren's disease. J Shoulder Elbow Surg 10 (2001) 149
111. Chilton C.P., Castle W.M., Westwood C.A., and Pryor J.P. Factors associated in the aetiology of peyronie's disease. Br J Urol 54 (1982) 748
112. Hellstrom W.J., and Bivalacqua T.J. Peyronie's disease: Etiology, medical, and surgical therapy. J Androl 21 (2000) 347
113. Qian A., Meals R.A., Rajfer J., and Gonzalez-Cadavid N.F. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. Urology 64 (2004) 399